|
|
||||||||||||||
|
|
|||||||||||||||
PAPER |
Department of Neurology, Greater Manchester Neurosciences Centre, Hope Hospital, Stott Lane, Salford, Manchester, UK
Correspondence to:
Correspondence to:
Dr S Duncan
Department of Neurology, Greater Manchester Neurosciences Centre, Hope Hospital, Stott Lane, Salford, Manchester M6 8 HD, UK; susanduncan{at}compuserve.com
Background: The National Institute for Clinical Excellence in the UK has issued guidelines stating all individuals with epilepsy be given information about sudden unexpected death in epilepsy (SUDEP).
Methods: We conducted a survey of current practice among UK neurologists, using a questionnaire sent to all practising neurologists in the UK listed on the Association of British Neurologists database, asking under what circumstances they told patients about SUDEP.
Results: Of the validated respondents, 5% discussed SUDEP with all patients, 26% with a majority, 61% with a few, and 7.5% with none. The commonest reasons for SUDEP to be discussed were the patient asking about it and the neurologist counselling people with known risk factors for SUDEP.
Conclusions: The variation we found, although not necessarily in tune with the guidelines, reflects the variation in patients need for knowledge about their condition.
Abbreviations: NICE, National Institute for Clinical Excellence; SIGN, Scottish Intercollegiate Guidelines Network; SpR, specialist registrar; SUDEP, sudden unexpected death in epilepsy
Keywords: epilepsy; SUDEP
This article has been cited by other articles:
![]() |
Doctors decide disclosure of sudden unexplained death J. Med. Ethics, May 1, 2006; 32(5): 255 - 255. [Full Text] [PDF] |
||||
![]() |
H. Marcovitch What's new this month in BMJ Journals BMJ, April 15, 2006; 332(7546): 904 - 904. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |